Elevated TGF-β1/IL-31 pathway is associated with the disease severity of Hepatitis B virus-related liver cirrhosis

Viral Immunology

Volumn 28, Issue 4, 2015, Pages 209-216

  Ming, Desong ^a   Yu, Xueping ^a   Guo, Ruyi ^a   Deng, Yong ^b   Li, Julan ^a   Lin, Chengzu ^a   Su, Milong ^a   Lin, Zhenzhong ^a   Su, Zhijun ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b Pingxiang People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; CREATININE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 31; INTERLEUKIN 33; INTERLEUKIN 35; INTERLEUKIN 9; TRANSFORMING GROWTH FACTOR BETA1; IL31 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ADULT; ALBUMIN BLOOD LEVEL; ALPHA FETOPROTEIN BLOOD LEVEL; ARTICLE; ASCITES; BLOOD ANALYSIS; CHRONIC HEPATITIS B; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; CREATININE BLOOD LEVEL; DECOMPENSATED LIVER CIRRHOSIS; DISEASE SEVERITY; ESOPHAGUS VARICES; FEMALE; FIBROGENESIS; HEPATITIS B VIRUS; HUMAN; HYPERSPLENISM; INFECTION; INVESTIGATIVE PROCEDURES; LEUKOCYTE COUNT; LIVER CELL DAMAGE; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER INJURY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT; AGED; BLOOD; COMPLICATION; HEPATITIS B; MIDDLE AGED; PATHOLOGY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

HEPATITIS B VIRUS;

ADULT; AGED; FEMALE; HEPATITIS B, CHRONIC; HUMANS; INTERLEUKINS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TRANSFORMING GROWTH FACTOR BETA1; YOUNG ADULT;

EID: 84928995920     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2014.0142     Document Type: Article

References (34)

1. Bartram U, and Speer CP the role of transforming growth factor beta in lung development and disease. Chest. 2004; 125: 754-765
2. Cornelissen C, Luscher-Firzlaff J, Baron JM., et al. Signaling by IL-31 and functional consequences. Eur J Cell Biol. 2012; 91: 552-566
3. Dunn C, Brunetto M, Reynolds G., et al. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exper Med. 2007; 204: 667-680
4. Ge Q, Moir LM, Black JL., et al. TGFbeta1 induces IL-6 and inhibits IL-8 release in human bronchial epithelial cells: the role of Smad2/3. J Cell Physiol. 2010; 225: 846-854
5. Kato A, Fujii E, Watanabe T., et al. Distribution of IL-31 and its receptor expressing cells in skin of atopic dermatitis. J Dermatol Sci. 2014; 74: 229-235
6. Knight D, Mutsaers SE, and Prele CM. STAT3 in tissue fibrosis: is there a role in the lung?. Pulm Pharmacol Ther. 2011; 24: 193-198
7. Lim YS, and Kim WR the global impact of hepatic fibrosis and end-stage liver disease. Clin Liver Dis. 2008; 12: 733-746, vii
8. Lok AS, and McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009; 50: 661-662
9. Miwa Y, Harrison PM, Farzaneh F., et al. Plasma levels and hepatic mRNA expression of transforming growth factorbeta1 in patients with fulminant hepatic failure. J Hepatol. 1997; 27: 780-788
10. Neis MM, Peters B, Dreuw A., et al. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis. J Allergy Clin Immunol. 2006; 118: 930-937
11. Ouyang H, Cheng J, Zheng Y., et al. Role of IL-31 in regulation of Th2 cytokine levels in patients with nasal polyps. Eur Arch Otorhinolaryngol. 2014; 271: 2703-2709
12. Papatheodoridis GV, and Manolakopoulos S. EASL clinical practice guidelines on the management of chronic hepatitis B: the need for liver biopsy. J Hepatol. 2009; 51: 226-227
13. Raap U, Wieczorek D, Gehring M., et al. Increased levels of serum IL-31 in chronic spontaneous urticaria. Exper Dermatol. 2010; 19: 464-466
14. Roberts AB, and Sporn MB. Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). Growth Factors. 1993; 8: 1-9
15. Schulz F, Marenholz I, Folster-Holst R., et al. A common haplotype of the IL-31 gene influencing gene expression is associated with nonatopic eczema. J Allergy Clin Immunol. 2007; 120: 1097-1102
16. Shen M, Chen K, Lu J., et al. Protective effect of astaxanthin on liver fibrosis through modulation of TGF-beta1 expression and autophagy. Mediat Inflamm. 2014; 2014: 954502
17. Shi K, Jiang J, Ma T., et al. Pathogenesis pathways of idiopathic pulmonary fibrosis in bleomycin-induced lung injury model in mice. Respir Physiol Neurobiol. 2014; 190: 113-117
18. Shiao YM, Chung HJ, Chen CC., et al. MCP-1 as an effector of IL-31 signaling in familial primary cutaneous amyloidosis. J Invest Dermatol. 2013; 133: 1375-1378
19. Sonkoly E, Muller A, Lauerma AI., et al. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol. 2006; 117: 411-417
20. Strain AJ, Frazer A, Hill DJ., et al. Transforming growth factor beta inhibits DNA synthesis in hepatocytes isolated from normal and regenerating rat liver. Biochem Biophys Res Commun. 1987; 145: 436-442
21. Sun HQ, Zhang JY, Zhang H., et al. Increased Th17 cells contribute to disease progression in patients with HBVassociated liver cirrhosis. J Viral Hepat. 2012; 19: 396-403
22. Ueberham E, Low R, Ueberham U., et al. Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis. Hepatology. 2003; 37: 1067-1078
23. Wang J, Cai Y, Ji H., et al. Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B. J Interferon Cytokine Res. 2012; 32: 248-253
24. Xu D, Fu J, Jin L., et al. Circulating and liver resident CD4 + CD25 + regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol. 2006; 177: 739-747
25. Xu L, Liu Q, and Wang J. Dynamic changes and effects of interleukin -31 and transform growth factor beta 1 in lung tissues of experimental mice with pulmonary fibrosis. J Heze Med College (in Chinese) 2011; 23: 1-3
26. Xu MY, Hu JJ, Shen J., et al. Stat3 signaling activation crosslinking of TGF-beta1 in hepatic stellate cell exacerbates liver injury and fibrosis. Biochim Biophys Acta. 2014; 1842: 2237-2245
27. Yoshimoto N, Togo S, Kubota T., et al. Role of transforming growth factor-beta1 (TGF-beta1) in endotoxin-induced hepatic failure after extensive hepatectomy in rats. J Endotoxin Res. 2005; 11: 33-39
28. Yu JI, Han WC, Yun KJ., et al. Identifying polymorphisms in IL-31 and their association with susceptibility to asthma. Korean J Pathol. 2012; 46: 162-168
29. Yu X, Guo R, Ming D., et al. Ratios of regulatory T cells/Thelper 17 cells and transforming growth factor-beta1/interleukin-17 to be associated with the development of hepatitis B virus-Associated liver cirrhosis. J Gastroenterol Hepatol. 2014; 29: 1065-1072
30. Zhang JY, Zhang Z, Lin F., et al. Interleukin-17-producing CD4( + ) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology. 2010; 51: 81-91
31. Zhang Z, Zou ZS, Fu JL., et al. Severe dendritic cell perturbation is actively involved in the pathogenesis of acute-onchronic hepatitis B liver failure. J Hepatol. 2008; 49: 396-406
32. Zhao J, Zhang Z, Luan Y., et al. Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment. Hepatology. 2014; 59: 1331-1342
33. Zou Y, Chen T, Han M., et al. Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure. J Immunol. 2010; 184: 466-475
34. Zou Z, Li B, Xu D., et al. Imbalanced intrahepatic cytokine expression of interferon-gamma, tumor necrosis factor-Alpha, and interleukin-10 in patients with acute-on-chronic liver failure associated with hepatitis B virus infection. J Clin Gastroenterol. 2009; 43: 182-190